Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 325

Results For "INST"

3306 News Found

Dr. Reddy's Sputnik V India price is Rs. 995.40
News | May 15, 2021

Dr. Reddy's Sputnik V India price is Rs. 995.40

The company is working closely with its six manufacturing partners in India


Dr. Reddy's Laboratories see marginal dip in FY 2021 PAT
News | May 15, 2021

Dr. Reddy's Laboratories see marginal dip in FY 2021 PAT

Dr. Reddy's Laboratories has reported total income of Rs.19338.9 crores during FY ended March 31, 2021


Cipla reports Q4FY21 consolidated net profit of Rs. 413.38 Cr
News | May 15, 2021

Cipla reports Q4FY21 consolidated net profit of Rs. 413.38 Cr

The company has reported total income of Rs.19425.58 crores during FY ended March 31, 2021


Gap between two doses of Covishield extended; No extension for Covaxin
News | May 14, 2021

Gap between two doses of Covishield extended; No extension for Covaxin

The COVID Working Group has recommended extension of the gap between the first and second doses of Covishield


Govt. to allow 100% doses of imported and ready to use foreign vaccine
News | May 14, 2021

Govt. to allow 100% doses of imported and ready to use foreign vaccine

Proactively engaging with foreign vaccine manufacturers like Moderna, Pfizer etc., to apply for Emergency Use Authorization in India so that these vaccines can be easily imported and made available in India


Eris Lifesciences reports Q4FY21 consolidated net profit of Rs. 68.24 Cr
News | May 13, 2021

Eris Lifesciences reports Q4FY21 consolidated net profit of Rs. 68.24 Cr

Eris Lifesciences has reported total income of Rs.1220.57 crores during the 12 months period ended March 31, 2021


Lupin reports Q4FY21 consolidated PAT of Rs. 460.36 Cr
News | May 13, 2021

Lupin reports Q4FY21 consolidated PAT of Rs. 460.36 Cr

It reported total income of Rs.15299.25 crores during the FY ended March 31, 2021


Vivimed Labs to manufacture, market Favipiravir tablets
News | May 11, 2021

Vivimed Labs to manufacture, market Favipiravir tablets

The tablets will be manufactured and marketed under Vivimed’s brand name “Favulous” across India


CRISIL assigns 'Positive' outlook to Jubilant Pharmova's long-term rating
News | May 11, 2021

CRISIL assigns 'Positive' outlook to Jubilant Pharmova's long-term rating

The rating withdrawal is based on the company’s request and in line with CRISIL Rating’s policy on withdrawal of ratings.


Alembic reports net profit of Rs. 71.94 Cr in Q4FY21
News | May 11, 2021

Alembic reports net profit of Rs. 71.94 Cr in Q4FY21

Alembic has reported total income of Rs.83.79 crores during the FY ended March 31, 2021